Nifty
Sensex
:
:
11828.25
39352.67
421.10 (3.69%)
1421.90 (3.75%)

Chemicals

Rating :
56/99

BSE: 530019 | NSE: JUBILANT

565.15
-30.35 (-5.10%)
20-May-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  594.00
  •  595.00
  •  550.05
  •  595.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  834149
  •  4714.19
  •  898.85
  •  550.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,024.07
  • 11.46
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 12,244.17
  • 0.53%
  • 1.95

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.86%
  • 11.11%
  • FII
  • DII
  • Others
  • 0.18%
  • 4.68%
  • 29.49%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.89
  • 5.31
  • 9.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.31
  • 8.26
  • 4.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.54
  • 42.59
  • 17.94

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.01
  • 18.17
  • 19.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.84
  • 2.31
  • 2.88

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.57
  • 9.56
  • 10.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
2,385.58
2,251.96
5.93%
2,377.10
2,067.76
14.96%
2,269.49
1,642.04
38.21%
2,078.65
1,596.05
30.24%
Expenses
2,027.61
1,794.09
13.02%
1,883.84
1,650.92
14.11%
1,819.31
1,335.98
36.18%
1,641.05
1,258.44
30.40%
EBITDA
357.97
457.87
-21.82%
493.26
416.84
18.33%
450.18
306.06
47.09%
437.60
337.61
29.62%
EBIDTM
15.01%
20.33%
20.75%
20.16%
19.84%
18.64%
21.05%
21.15%
Other Income
-6.58
22.91
-
29.02
3.22
801.24%
3.83
7.09
-45.98%
9.47
6.81
39.06%
Interest
61.59
72.48
-15.02%
68.27
77.06
-11.41%
62.72
66.01
-4.98%
72.70
68.73
5.78%
Depreciation
95.02
181.74
-47.72%
98.40
81.82
20.26%
89.48
79.01
13.25%
88.00
72.48
21.41%
PBT
-39.98
226.56
-
355.61
261.18
36.16%
301.81
168.13
79.51%
286.37
203.21
40.92%
Tax
60.67
74.16
-18.19%
88.09
48.34
82.23%
92.04
42.66
115.75%
86.00
59.50
44.54%
PAT
-100.65
152.40
-
267.52
212.84
25.69%
209.77
125.47
67.19%
200.37
143.71
39.43%
PATM
-4.22%
6.77%
11.25%
10.29%
9.24%
7.64%
9.64%
9.00%
EPS
-6.23
9.94
-
16.74
13.64
22.73%
13.51
8.24
63.96%
13.00
9.45
37.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
3,517.98
Net Sales Growth
20.55%
28.26%
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
-9.11%
7.76%
 
Cost Of Goods Sold
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
1,352.42
Gross Profit
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
2,165.57
GP Margin
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
61.56%
Total Expenditure
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
2,834.73
Power & Fuel Cost
-
424.91
333.66
366.71
393.04
389.74
356.73
286.89
224.04
220.03
197.91
% Of Sales
-
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
5.63%
Employee Cost
-
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
735.21
648.49
% Of Sales
-
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
18.43%
Manufacturing Exp.
-
485.98
428.84
436.46
432.40
405.14
360.48
329.75
284.66
315.90
293.91
% Of Sales
-
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
8.35%
General & Admin Exp.
-
365.54
280.98
256.23
302.28
264.23
208.35
200.72
195.72
196.68
191.38
% Of Sales
-
4.86%
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
5.44%
Selling & Distn. Exp.
-
247.85
185.79
135.54
203.98
160.04
123.28
111.85
90.92
125.97
124.22
% Of Sales
-
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
3.53%
Miscellaneous Exp.
-
56.78
53.20
65.96
39.72
19.59
23.53
28.50
27.21
46.18
124.22
% Of Sales
-
0.76%
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
0.75%
EBITDA
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
680.06
683.25
EBITDA Margin
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
19.42%
Other Income
35.74
40.03
24.86
13.37
42.45
19.06
29.87
31.48
17.24
118.09
106.66
Interest
265.28
284.28
341.11
371.35
367.61
337.11
310.93
238.23
119.99
155.57
330.09
Depreciation
370.90
415.05
291.40
346.74
287.95
281.17
253.79
220.65
180.10
124.68
163.24
PBT
903.81
859.08
737.64
542.22
88.43
421.78
533.29
462.79
282.02
517.90
296.58
Tax
326.80
224.66
163.02
155.40
80.48
69.64
152.36
68.41
13.37
95.94
26.72
Tax Rate
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
9.01%
PAT
577.01
642.81
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
421.46
283.18
PAT before Minority Interest
574.46
634.42
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
421.95
269.86
Minority Interest
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
13.32
PAT Margin
6.33%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
8.05%
PAT Growth
-9.05%
11.66%
46.92%
-
-
-28.61%
948.97%
-93.66%
-45.49%
48.83%
 
Unadjusted EPS
37.02
41.25
36.93
25.10
-3.63
6.85
9.59
0.91
14.42
28.56
19.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
1,542.64
Share Capital
15.58
15.57
15.54
15.93
15.45
15.93
15.93
15.93
15.88
14.76
Total Reserves
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
1,527.89
Non-Current Liabilities
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
4,056.86
Secured Loans
1,109.17
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
2,966.30
Unsecured Loans
1,938.64
1,923.07
392.79
375.00
0.22
760.06
0.45
400.61
1,011.94
975.49
Long Term Provisions
107.08
80.69
70.31
67.04
219.53
237.96
169.70
39.87
0.00
0.00
Current Liabilities
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
1,130.63
Trade Payables
1,136.16
749.49
612.12
721.19
718.14
647.13
836.98
517.43
688.83
584.06
Other Current Liabilities
505.87
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
64.70
88.72
Short Term Borrowings
244.85
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
0.00
0.00
Short Term Provisions
117.81
106.24
151.93
97.49
257.25
101.84
109.18
403.28
466.59
457.85
Total Liabilities
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
6,762.08
Net Block
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
3,745.00
Gross Block
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
4,648.26
Accumulated Depreciation
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
903.26
Non Current Assets
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
4,281.34
Capital Work in Progress
670.97
683.78
611.32
596.60
472.39
436.89
685.55
666.71
505.63
503.12
Non Current Investment
123.52
102.71
85.43
39.50
33.99
25.61
19.20
32.75
32.70
33.22
Long Term Loans & Adv.
71.79
56.32
62.67
327.17
328.42
379.47
299.86
249.18
0.00
0.00
Other Non Current Assets
0.58
1.08
0.53
29.68
2.21
0.37
0.79
0.55
0.00
0.00
Current Assets
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
2,205.31
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
223.71
238.13
Inventories
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
595.61
Sundry Debtors
1,130.76
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
518.61
504.41
Cash & Bank
248.79
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
503.67
381.66
Other Current Assets
418.81
225.73
244.07
121.03
301.21
380.29
357.59
334.88
518.27
485.49
Short Term Loans & Adv.
45.75
37.06
133.06
144.56
136.04
182.01
256.70
217.50
498.14
444.09
Net Current Assets
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
84.53
322.08
1,235.11
1,074.69
Total Assets
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51
6,762.08

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
709.61
558.06
PBT
859.08
737.64
542.22
40.32
207.28
341.14
114.11
240.59
517.90
296.58
Adjustment
687.81
637.90
737.89
725.84
756.60
752.36
795.44
318.42
189.22
352.94
Changes in Working Capital
14.15
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
62.58
-55.56
Cash after chg. in Working capital
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
769.70
593.96
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
-41.99
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
-2,030.73
Net Fixed Assets
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
-492.68
Net Investments
3.34
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
-159.67
-331.27
Others
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
-1,206.78
Cash from Financing Activity
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
1,150.66
Net Cash Inflow / Outflow
-215.63
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
131.84
-322.01
Opening Cash & Equivalents
456.44
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
381.66
523.77
Closing Cash & Equivalent
244.18
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15
505.34
375.89

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
262.33
220.61
190.90
154.04
170.07
155.46
141.70
136.38
137.88
85.89
ROA
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
4.93%
ROE
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
21.40%
ROCE
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
14.62%
Fixed Asset Turnover
1.26
1.09
0.92
0.81
0.84
0.82
0.78
0.70
0.82
1.02
Receivable days
51.58
59.43
54.81
49.56
46.53
47.00
48.71
53.83
48.18
46.63
Inventory Days
63.07
73.64
75.51
78.58
75.51
73.76
71.07
71.61
60.59
51.66
Payable days
56.86
54.84
53.44
52.17
51.42
45.33
38.70
50.95
58.42
49.77
Cash Conversion Cycle
57.79
78.23
76.88
75.98
70.61
75.42
81.08
74.50
50.34
48.52
Total Debt/Equity
0.85
1.18
1.51
1.95
1.67
1.71
1.69
1.81
1.45
3.11
Interest Cover
4.02
3.16
2.46
1.11
1.61
2.10
1.48
3.01
4.33
1.90

News Update:


  • Jubilant Life Sciences’ arm adds advanced Pioneer FE system to its platform
    20th May 2019, 11:50 AM

    The Pioneer FE system from ForteBio, the Biologics Business Unit of Molecular Devices

    Read More
  • Jubilant Life Sciences reports net loss of Rs 101 crore in Q4 consolidated
    18th May 2019, 12:32 PM

    Total consolidated income of the company rose marginally by 4.58% at Rs 2,379.00 crore for the quarter ended March 31, 2019

    Read More
  • Jubilant LifeScience - Quarterly Results
    17th May 2019, 16:05 PM

    Read More
  • Jubilant Life Sciences raises Rs 100 crore via CP
    18th Apr 2019, 14:14 PM

    The tenure of instrument is 68 days and the coupon rate is 7.18% pa

    Read More
  • Jubilant Life Sciences’ arm settles Zero Coupon Convertible Loan of IFC
    30th Mar 2019, 09:21 AM

    With the above payment of the convertible loan, all loans outstanding to IFC have been fully paid

    Read More
  • Jubilant Life Sciences’ arm gets USFDA warning letter for Roorkee facility
    8th Mar 2019, 14:05 PM

    The USFDA may withhold approval of any new applications till the company addresses all issues raised by the agency

    Read More
  • Jubilant Life Sciences’ arm to raise funds through Bonds
    1st Mar 2019, 09:24 AM

    Fitch Ratings (Fitch) has affirmed ‘BB-/Stable’ rating for JPL

    Read More
  • Jubilant Life Sciences’ arm to launch offering of bonds outside India
    25th Feb 2019, 09:16 AM

    The Board of Directors of Jubilant Pharma at its meeting held on February 25, 2019 has approved the same

    Read More
  • Jubilant Life Sciences raises Rs 75 crore via CP
    21st Feb 2019, 09:40 AM

    The tenure of instrument is 36 days and the coupon rate is 6.98% pa

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.